ArticleTherapeutic advances in gastroenterology2025
Evaluation of inflammatory bowel disease-related sleep disorders based on an interpretable machine learning approach: a multicenter study in China.
Article in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with inflammatory bowel disease (IBD) often encounter complications such as sleep disorders, which are of great detriment to their quality of life, and earlier identification and intervention can effectively improve the prognosis of patients. Objectives: In this study, we worked on building a risk model to assess IBD-related sleep disorders using a machine learning (ML) approach. Design: Observational study. Methods: Based on an online questionnaire, we collected clinical data from 2478 IBD patients from 42 hospitals in 22 Chinese provinces between September 2021 and May 2022. Then, we developed and validated six common ML models to assess the risk of co-morbid sleep disorders in IBD patients, and evaluated and compared the performance of these models using relevant metrics. Finally, the Local Interpretable Model-Agnostic Explanations algorithm (Lime) was utilized to interpret the results of the best ML model. Results: In this study, after multidimensional comparisons, the voting model was finally identified as superior among several models, with the area under the curve and accuracy reaching 0.76 and 0.74, respectively. After calculations, it was found that the co-morbidities of depression and anxiety, an older age, outpatient diagnosis, and a longer course of the disease were all indicative of a higher risk of sleep disorders among IBD patients in this model. Conclusion: The construction of risk assessment models using ML has high clinical value in the prediction of IBD-related sleep disorders, and the efficacy of its application suggests it can serve as a promising evaluation tool in clinical work.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.